Is axillary clearance the standard of care for breast cancer patients with sentinel node involvement?

Future Oncology

Volumn 2, Issue 5, 2006, Pages 621-626

  Fentiman, Ian S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Axillary dissection; Breast cancer; Nomogram; Nonsentinel node; Prediction; Sentinel node

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SIZE; CANCER STAGING; CANCER THERAPY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; NOMOGRAM; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; STANDARDIZATION;

AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 33750045440     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.2.5.621     Document Type: Article

References (32)

1. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann. Surg. Oncol. 6, 109-116 (1999).
2. Lyman GH, Giuliano AE, Somerfield MR et al: American Society of Clinical Oncology Guideline recommendations for sentinel node biopsy in early stage breast cancer. J. Clin. Oncol. 23. 7703-7720 (2005).
3. Millis RR, Springall R, Lee AHS. Ryder K, Rytina ERC. Fentiman IS: Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br. J. Cancer 86, 396-401 (2002).
4. Cserni G, Gregori D, Merletti F et al.: Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br. J. Surg. 91, 1245-1252 (2004).
5. Wong SL, Edwards MJ, Chao C et al.: Predicting the status of the nonsentinel lymph nodes. Arch. Surg. 136, 563-568 (2001).
6. Nos C, Harding-MacKean C, Fréneaux P et al: Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br. J. Surg. 90, 1354-1360 (2003).
7. Dabbs DJ, Fung M, Landsittel D. McManus K, Johnson R: Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J. 10, 101-105 (2004).
8. Viale G, Maiorano E. Pruneri G et al.: Predicting the risk for additional metastases in patients with breast carcinoma and positive sentinel lymph nodes. Ann. Surg. 241, 319-325 (2005).
9. Gipponi M, Canavese G, Lionetto R et al.: The role of axillary lymph node dissection in breast cancer patients with sentinel node micrometastases. Eur. J. Surg. Oncol. 32, 143-147 (2006).
10. Yu JC, Hsu GC, Hsieh CB, Sheu LF, Chao TY: Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J. Surg. 29, 813-818 (2005).
11. Schrenk P, Konstanriniuk P, Wölfl S et al.: Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br. J. Surg. 92, 707-713 (2005).
12. Kuijt GP, van de Poll-Franse LV, Roumen RMH, van Beck MWPM, Voogd AC: The significance of one positive axillary node. Eur. J. Surg. 32, 139-142 (2006).
13. Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A: Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur. J. Surg. Oncol. 32, 29-33 (2006).
14. Stitzenberg KB, Meyer AA, Stern SL et al.: Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann. Surg. 237, 607-613 (2003).
15. Joseph K-A, El-Tamer M, Komenaka I, Troxel A, Ditkopff BA, Schnabel F: Predictors of nonsentinel node metastasts in patients with breast cancer after sentinel node metastasis. Arch. Surg. 139, 648-651 (2004).
16. Fisher B, Jeong J-H, Anderson S, Bryant J, Fisher ER, Wolmark N: Twenty-tive-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N. Engl. J. Med. 347, 567-575 (2002).
17. Cancer Research Campaign Working Party: Cancer research campaign (King's/ Cambridge) trial for early breast cancer: a detailed update at the tenth year. Lancet 2, 55-60 (1980).
18. Fentiman IS: Long-term follow-up of the first breast conservation trial (Guy's Wide Excision Study). Breast J. 9, 5-8 (2000).
19. Axelsson CK, Mouridsen HT, Zedeler K: Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur. J. Cancer 28, 1415-1418 (1992).
20. Shukla HS, Melhuish J, Mansel RE, Hughes LE: Does local therapy affect survival rates in breast cancer? Ann. Surg. Oncol. 6, 420-421 (1999).
21. Kingsmore DB, Ssemwogerere A, Hole DJ, Gillis CR, George WD: Increased mortality from breast cancer and inadequate axillary treatment. Breast 12, 36-41 (2003).
22. Overgaard M, Christensen JJ, Johansen H et al.: Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Co-operative Group (DBCCG 82) trial. Int. J. Radiat. Oncol. Biol. Phys. 19, 1121-1124 (1990).
23. Reed DR, Lindstey SK, Mann GN et al.: Axillary lymph node dose with tangential breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 61, 358-364 (2005).
24. Rutgers EJ, Meijnen P, Bonnefoi H: Clinical trials update of the European Organisation for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res. 6, 165-169 (2004).
25. Forrest AP, Everington D, McDonald C et al.: The Edinburgh randomised trial of axillary sampling or clearance after mastectomy. Br. J. Surg. 82, 1504-1508 (1995).
26. Veronesi U, Paganelli G, Viale G et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med. 349, 546-553 (2003).
27. Van Zee KJ, Manasseh D-ME, Bevilacqua JLB et al.: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann. Surg. Oncol. 10, 1140-1151 (2003).
28. Soni NK, Carmatt HL, Gillett DJ, Spillane AJ: Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur. J. Surg. Oncol. 31, 958-964 (2005).
29. Smidt ML, Kuster DM, Van der Wilt G, Thunnissen FB, Van Zee KJ, Strobbe LJA: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel node metastases in breast cancer patients in the Netherlands? Ann. Surg. Oncol. 12, 1066-1072 (2005).
30. Degnim AC, Reynolds C, Pantvaidya G et al.: Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am. J. Surg. 190, 543-550 (2005).
31. Koesis L, Svebis M, Boross G et al.: Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Ann. Surg. 70, 1019-1024 (2004).
32. Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ: Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann. Surg. Oncol. 12, 654-659 (2005).